The 1‑year safety and efficacy outcomes of Absorb bioresorbable vascular scaffolds for coronary artery disease treatment in diabetes mellitus patients: the ABSORB DM Benelux study

BACKGROUND: Diabetes mellitus (DM) patients show higher rates of repeat revascularisation even in the era of modern drug-eluting stents (DES). The concept of bioresorbable scaffolds is becoming captivating, as it might allow for repeat interventions, prolonging the time span during which patients ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Hommels, T. M., Hermanides, R. S., Rasoul, S., Berta, B., IJsselmuiden, A. J. J., Jessurun, G. A. J., Benit, E., Pereira, B., De Luca, G., Kedhi, E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bohn Stafleu van Loghum 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6823340/
https://www.ncbi.nlm.nih.gov/pubmed/31197750
http://dx.doi.org/10.1007/s12471-019-1293-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6823340/
https://www.ncbi.nlm.nih.gov/pubmed/31197750
http://dx.doi.org/10.1007/s12471-019-1293-7

Ejemplares similares